The Significance of Glycolysis in Tumor Progression and Its Relationship with the Tumor Microenvironment

Overview

Journal Front Pharmacol

Date 2023 Jan 2

PMID 36588722

Authors

Daoying Zhou

Zhen Duan

Zhenyu Li

Fangfang Ge

Ran Wei

Lingsuo Kong

Affiliations

Soon will be listed here.

Abstract

It is well known that tumor cells rely mainly on aerobic glycolysis for energy production even in the presence of oxygen, and glycolysis is a known modulator of tumorigenesis and tumor development. The tumor microenvironment (TME) is composed of tumor cells, various immune cells, cytokines, and extracellular matrix, among other factors, and is a complex niche supporting the survival and development of tumor cells and through which they interact and co-evolve with other tumor cells. In recent years, there has been a renewed interest in glycolysis and the TME. Many studies have found that glycolysis promotes tumor growth, metastasis, and chemoresistance, as well as inhibiting the apoptosis of tumor cells. In addition, lactic acid, a metabolite of glycolysis, can also accumulate in the TME, leading to reduced extracellular pH and immunosuppression, and affecting the TME. This review discusses the significance of glycolysis in tumor development, its association with the TME, and potential glycolysis-targeted therapies, to provide new ideas for the clinical treatment of tumors.

Citing Articles

Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance.

Suri C, Pande B, Suhasini Sahithi L, Swarnkar S, Khelkar T, Verma H Cancer Drug Resist. 2025; 8:7.

PMID: 40051496 PMC: 11883236. DOI: 10.20517/cdr.2024.164.

Wash-free fluorescent tools based on organic molecules: Design principles and biomedical applications.

Tan J, Wang C, Hu Z, Zhang X Exploration (Beijing). 2025; 5(1):20230094.

PMID: 40040824 PMC: 11875451. DOI: 10.1002/EXP.20230094.

"Friends or foes": a new perspective of tumour metabolic transcriptional modification.

Shi T, Geng Q, Wang Z, Wen C, Xu J, Jiao Y Cell Death Dis. 2025; 16(1):106.

PMID: 39962057 PMC: 11833121. DOI: 10.1038/s41419-025-07429-y.

Mechanistic insights into the role of traditional Chinese medicine in treating gastric cancer.

Chen Z, Yu T, Wang Y, Li J, Zhang B, Zhou L Front Oncol. 2025; 14:1443686.

PMID: 39906672 PMC: 11790455. DOI: 10.3389/fonc.2024.1443686.

MOX Nanosensors to Detect Colorectal Cancer Relapses from Patient's Blood at Three Years Follow-Up, and Gender Correlation.

Astolfi M, Zonta G, Malagu C, Anania G, Rispoli G Biosensors (Basel). 2025; 15(1).

PMID: 39852107 PMC: 11764080. DOI: 10.3390/bios15010056.

References

Lu J, Xu Z, Duan H, Ji H, Zhen Z, Li B . Tumor-associated macrophage interleukin-β promotes glycerol-3-phosphate dehydrogenase activation, glycolysis and tumorigenesis in glioma cells. Cancer Sci. 2020; 111(6):1979-1990. PMC: 7293068. DOI: 10.1111/cas.14408. View

Xu W, Liu W, Xu Y, Tian X, Anwaier A, Su J . Hexokinase 3 dysfunction promotes tumorigenesis and immune escape by upregulating monocyte/macrophage infiltration into the clear cell renal cell carcinoma microenvironment. Int J Biol Sci. 2021; 17(9):2205-2222. PMC: 8241725. DOI: 10.7150/ijbs.58295. View

Dominski A, Krawczyk M, Konieczny T, Kasprow M, Forys A, Pastuch-Gawolek G . Biodegradable pH-responsive micelles loaded with 8-hydroxyquinoline glycoconjugates for Warburg effect based tumor targeting. Eur J Pharm Biopharm. 2020; 154:317-329. DOI: 10.1016/j.ejpb.2020.07.019. View

Hu X, Xu Q, Wan H, Hu Y, Xing S, Yang H . PI3K-Akt-mTOR/PFKFB3 pathway mediated lung fibroblast aerobic glycolysis and collagen synthesis in lipopolysaccharide-induced pulmonary fibrosis. Lab Invest. 2020; 100(6):801-811. DOI: 10.1038/s41374-020-0404-9. View

Yan S, Li Q, Zhang D, Wang X, Xu Y, Zhang C . Necroptosis pathway blockage attenuates PFKFB3 inhibitor-induced cell viability loss and genome instability in colorectal cancer cells. Am J Cancer Res. 2021; 11(5):2062-2080. PMC: 8167677. View

Ganapathy-Kanniappan S . Taming Tumor Glycolysis and Potential Implications for Immunotherapy. Front Oncol. 2017; 7:36. PMC: 5346534. DOI: 10.3389/fonc.2017.00036. View

Tan Q, Huang Q, Ma Y, Mao K, Yang G, Luo P . Potential roles of IL-1 subfamily members in glycolysis in disease. Cytokine Growth Factor Rev. 2018; 44:18-27. DOI: 10.1016/j.cytogfr.2018.11.001. View

Guo D, Tong Y, Jiang X, Meng Y, Jiang H, Du L . Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα. Cell Metab. 2022; 34(9):1312-1324.e6. DOI: 10.1016/j.cmet.2022.08.002. View

Chang C, Qiu J, OSullivan D, Buck M, Noguchi T, Curtis J . Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression. Cell. 2015; 162(6):1229-41. PMC: 4864363. DOI: 10.1016/j.cell.2015.08.016. View

10.

Jin M, Jin W . The updated landscape of tumor microenvironment and drug repurposing. Signal Transduct Target Ther. 2020; 5(1):166. PMC: 7447642. DOI: 10.1038/s41392-020-00280-x. View

11.

Wang X, Zhang H, Yang H, Bai M, Ning T, Deng T . Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer. Mol Oncol. 2020; 14(3):539-555. PMC: 7053238. DOI: 10.1002/1878-0261.12629. View

12.

Pavlova N, Thompson C . The Emerging Hallmarks of Cancer Metabolism. Cell Metab. 2016; 23(1):27-47. PMC: 4715268. DOI: 10.1016/j.cmet.2015.12.006. View

13.

Gao P, Shen S, Li X, Liu D, Meng Y, Liu Y . Dihydroartemisinin Inhibits the Proliferation of Leukemia Cells K562 by Suppressing PKM2 and GLUT1 Mediated Aerobic Glycolysis. Drug Des Devel Ther. 2020; 14:2091-2100. PMC: 7261662. DOI: 10.2147/DDDT.S248872. View

14.

Cao H, Huang T, Dai M, Kong X, Liu H, Zheng Z . Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies. Int J Biol Sci. 2022; 18(14):5369-5390. PMC: 9461676. DOI: 10.7150/ijbs.73949. View

15.

Zhang J, Yang J, Lin C, Liu W, Huo Y, Yang M . Endoplasmic Reticulum stress-dependent expression of ERO1L promotes aerobic glycolysis in Pancreatic Cancer. Theranostics. 2020; 10(18):8400-8414. PMC: 7381747. DOI: 10.7150/thno.45124. View

16.

Hsu P, Sabatini D . Cancer cell metabolism: Warburg and beyond. Cell. 2008; 134(5):703-7. DOI: 10.1016/j.cell.2008.08.021. View

17.

Ghanavat M, Shahrouzian M, Zayeri Z, Banihashemi S, Kazemi S, Saki N . Digging deeper through glucose metabolism and its regulators in cancer and metastasis. Life Sci. 2020; 264:118603. DOI: 10.1016/j.lfs.2020.118603. View

18.

Chandel N . Glycolysis. Cold Spring Harb Perspect Biol. 2021; 13(5). PMC: 8091952. DOI: 10.1101/cshperspect.a040535. View

19.

Li S, He P, Wang Z, Liang M, Liao W, Huang Y . RNAi-mediated knockdown of PFK1 decreases the invasive capability and metastasis of nasopharyngeal carcinoma cell line, CNE-2. Cell Cycle. 2021; 20(2):154-165. PMC: 7889105. DOI: 10.1080/15384101.2020.1866279. View

20.

Yang X, Zhang T, Zhang X, Chu C, Sang S . Global burden of lung cancer attributable to ambient fine particulate matter pollution in 204 countries and territories, 1990-2019. Environ Res. 2021; 204(Pt A):112023. DOI: 10.1016/j.envres.2021.112023. View